WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, April 1, 2009, 29(13):4252-4262; doi:10.1523/JNEUROSCI.5572-08.2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mandrekar, S.
Right arrow Articles by Landreth, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mandrekar, S.
Right arrow Articles by Landreth, G. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYTOCHALASIN D

 Previous Article  |  Next Article 

Neurobiology of Disease
Microglia Mediate the Clearance of Soluble Aβ through Fluid Phase Macropinocytosis

Shweta Mandrekar,1 Qingguang Jiang,1 C. Y. Daniel Lee,1 Jessica Koenigsknecht-Talboo,2 David M. Holtzman,2 and Gary E. Landreth1

1Alzheimer Research Laboratory, Department of Neurosciences, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, and 2Department of Neurology and Hope Center for Neurological Disorders, Washington University, St. Louis, Missouri 63110

Correspondence should be addressed to Gary E. Landreth, Alzheimer Research Laboratory, Department of Neurosciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106. Email: gel2{at}cwru.edu

Alzheimer's disease is characterized by the progressive deposition of β-amyloid (Aβ) within the brain parenchyma and its subsequent accumulation into senile plaques. Pathogenesis of the disease is associated with perturbations in Aβ homeostasis and the inefficient clearance of these soluble and insoluble peptides from the brain. Microglia have been reported to mediate the clearance of fibrillar Aβ (fAβ) through receptor-mediated phagocytosis; however, their participation in clearance of soluble Aβ peptides (sAβ) is largely unknown. We report that microglia internalize sAβ from the extracellular milieu through a nonsaturable, fluid phase macropinocytic mechanism that is distinct from phagocytosis and receptor-mediated endocytosis both in vitro and in vivo. The uptake of sAβ is dependent on both actin and tubulin dynamics and does not involve clathrin assembly, coated vesicles or membrane cholesterol. Upon internalization, fluorescently labeled sAβ colocalizes to pinocytic vesicles. Microglia rapidly traffic these soluble peptides into late endolysosomal compartments where they are subject to degradation. Additionally, we demonstrate that the uptake of sAβ and fAβ occurs largely through distinct mechanisms and upon internalization are segregated into separate subcellular vesicular compartments. Significantly, we found that upon proteolytic degradation of fluorescently labeled sAβ, the fluorescent chromophore is retained by the microglial cell. These studies identify an important mechanism through which microglial cells participate in the maintenance of Aβ homeostasis, through their capacity to constitutively clear sAβ peptides from the brain.


Received Nov. 21, 2008; revised Feb. 5, 2009; accepted March 2, 2009.

Correspondence should be addressed to Gary E. Landreth, Alzheimer Research Laboratory, Department of Neurosciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106. Email: gel2{at}cwru.edu




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
Y. Doi, T. Mizuno, Y. Maki, S. Jin, H. Mizoguchi, M. Ikeyama, M. Doi, M. Michikawa, H. Takeuchi, and A. Suzumura
Microglia Activated with the Toll-Like Receptor 9 Ligand CpG Attenuate Oligomeric Amyloid {beta} Neurotoxicity in in Vitro and in Vivo Models of Alzheimer's Disease
Am. J. Pathol., November 1, 2009; 175(5): 2121 - 2132.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. G. Reed-Geaghan, J. C. Savage, A. G. Hise, and G. E. Landreth
CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar A{beta}-Stimulated Microglial Activation
J. Neurosci., September 23, 2009; 29(38): 11982 - 11992.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-